Anti-Müllerian hormone and cardiovascular risk in males with chronic kidney disease: A protocol.

患有慢性肾病的男性的抗苗勒氏管激素和心血管风险：一个方案。

• 批准号: 481028
• 负责人: Larsen Nicole
• 金额: $ 0.05万
• 依托单位: University of Calgary
• 依托单位国家: 加拿大
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-01-01 至 2024-01-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=481028&lang=en
• 关键词: Amh; Anti-Muellerian Hormone; Cardiovascular; Ckd

This research project will improve our understanding of AMH as a potential novel CV risk predictor for males with CKD and may inform clinical decision-making in CV disease prevention in this high-risk population.

该研究项目将提高我们对AMH作为CKD男性潜在的新型CV风险预测因子的理解，并可能为这一高危人群预防CV疾病的临床决策提供信息。